Inflation Reduction Act's Medicare Prescription Payment Plan: New CMS Guidance
Navigating New Pharmacy Processes and Implications for Reimbursement
This program is cancelled
A live 90-minute CLE video webinar with interactive Q&A
This CLE will provide guidance to healthcare counsel on the Inflation Reduction Act's (IRA) Medicare Prescription Payment Plan. The panel will examine the new CMS guidance as well as the operational changes and requirements necessary to implement the changes. The panel will also discuss the potential implications for reimbursement and offer best practices for implementing the changes.
Outline
- CMS guidance
- Plan requirements and implementation
- Potential implications for reimbursement
- Best practices
Benefits
The panel will review these and other key considerations:
- What guidance has been provided as to how the payment plan works?
- What parameters does the guidance place on sponsors to effectuate new processes?
- What impact may the IRA Payment Plan have on reimbursement?
Faculty
Michael P. Gennett
Shareholder
Polsinelli
Mr. Gennett is a healthcare regulatory attorney with 25 years of experience representing healthcare providers. He... | Read More
Mr. Gennett is a healthcare regulatory attorney with 25 years of experience representing healthcare providers. He focuses his practice on state licensing, Medicare and Medicaid compliance, HIPAA, and other regulatory issues. Mr. Gennett represents healthcare clinicians and companies, including medical practices, medical equipment companies, pharmacies and home health agencies. He has successfully defended healthcare providers in Medicare and Medicaid overpayment appeals, investigations and other program integrity efforts by government contractors. In addition, Mr. Gennett has worked on False Claims Act whistleblower cases and data breaches. He is currently a member of The Florida Bar Health Law Executive Council and is Chair of the Health Law Continuing Legal Education Committee.
Close
Mary L. Hendrickson
Special Counsel
Foley & Lardner
Ms. Hendrickson draws on her years of in-house experience to help clients navigate regulatory laws and compliance... | Read More
Ms. Hendrickson draws on her years of in-house experience to help clients navigate regulatory laws and compliance programs, as well as transactional matters. She has extensive experience advising pharmacies and healthcare entities, including health systems and healthcare providers, wholesale distributors, reverse pharmaceutical distributors, pharmaceutical manufacturers, and PBMs on various regulatory, transactional, and compliance program matters. Ms. Hendrickson has in-depth experience evaluating, restructuring, and advancing compliance programs of all sizes and advising executive management and board members on compliance matters, including the audit committee’s responsibility associated with compliance program oversight and enterprise risk management programs.
Close
Matthew K. Loughran
Health Policy Analyst
Reed Smith
Mr. Loughran monitors federal and state policy developments coming out of CMS, OIG, HHS, FDA and other federal and... | Read More
Mr. Loughran monitors federal and state policy developments coming out of CMS, OIG, HHS, FDA and other federal and state agencies. He focuses primarily on federal and state health laws and regulations; Medicare and Medicaid payment systems; healthcare fraud & abuse litigation and enforcement; healthcare transaction regulation; and pharmaceutical manufacturing and distribution regulation, helping healthcare and life sciences clients understand and implement changes in health care policy. In addition, Mr. Loughran is the editor of Reed Smith's "Health Industry Washington Watch" blog, which offers ongoing reporting of legislative and regulatory developments affecting Medicare and Medicaid reimbursement, fraud and abuse developments and other health care regulatory changes. He also is a frequent author of articles and analyses regarding federal health policy.
Close